Bilateral Dual TAP Block: Description of a Novel Four-point Approach
NCT ID: NCT01040234
Last Updated: 2015-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2009-11-30
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty
NCT01604694
Does the Application of a Bilateral-dual Transverse Abdominal Plane (TAP)Block Have an Influence on Lung Function?
NCT01254812
Ultrasound-guided Transversus Abdominis Plane Block After Hysterectomy
NCT01153503
Role of Ultrasound Guided Transversus Abdominis Plane Block in Pain Control After Hepatectomy
NCT06224179
Study Comparing Two Methods of TransversusAbdominis Plane
NCT04108221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active pain treatment
Bilateral dual TAP block
Bilateral dual TAP block
Bupivacaine 2.5 mg/ml 15 ml per injection. 4 injections per patient according to dual TAP block procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bilateral dual TAP block
Bupivacaine 2.5 mg/ml 15 ml per injection. 4 injections per patient according to dual TAP block procedure
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kenneth Jensen, MD, BBA
MD, BBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens N Børglum, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Dept Z, Bispebjerg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept Z, Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BBH_Z-Regional-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.